StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
224
This month
2
This year
23
Publishing Date
2024 - 03 - 11
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 01 - 30
2
2023 - 10 - 04
3
2023 - 08 - 30
2
2023 - 07 - 21
2
2023 - 07 - 10
2
2023 - 05 - 19
2
2023 - 04 - 13
3
2023 - 03 - 10
2
2023 - 01 - 25
2
2023 - 01 - 09
2
2022 - 11 - 28
2
2022 - 11 - 21
2
2022 - 09 - 29
2
2022 - 09 - 28
2
2022 - 09 - 27
2
2022 - 09 - 26
2
2022 - 09 - 15
3
2022 - 09 - 12
3
2022 - 09 - 08
3
2022 - 09 - 05
2
2022 - 08 - 03
3
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 24
3
2022 - 06 - 07
2
2022 - 05 - 31
3
2022 - 05 - 20
2
2022 - 04 - 07
2
2022 - 04 - 04
2
2022 - 03 - 26
2
2022 - 02 - 28
2
2022 - 02 - 26
2
2022 - 02 - 18
2
2022 - 02 - 04
1
2022 - 01 - 31
1
2022 - 01 - 28
1
2022 - 01 - 19
2
2022 - 01 - 11
1
2022 - 01 - 07
1
2021 - 12 - 13
1
2021 - 12 - 11
1
2021 - 12 - 08
1
2021 - 11 - 12
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 10 - 25
1
2021 - 10 - 22
1
2021 - 10 - 20
1
2021 - 10 - 14
1
2021 - 10 - 08
2
2021 - 10 - 07
1
2021 - 10 - 05
1
2021 - 10 - 04
1
2021 - 09 - 30
1
2021 - 09 - 29
1
2021 - 09 - 28
1
Sector
Communications
2
Consumer durables
1
Consumer non-durables
5
Electronic technology
1
Health services
1
Health technology
224
Manufacturing
28
Mining, quarrying, and oil and gas extraction
1
N/a
16
Process industries
4
Producer manufacturing
2
Professional, scientific, and technical services
2
Retail trade
1
Technology services
1
Tags
Abbvie
3
Active
6
America
16
Antibiotics
3
Antibody
3
Approval
4
Approved
3
Asia
3
Breast
3
Cancer
14
Care
3
Casirivimab
4
Children
18
Clinical-trials-phase-iii
4
Collaboration
6
Covid
5
Covid-19
4
Crispr
3
Dermatitis
7
Disease
17
Drug
17
Drug delivery
3
Dupixent
34
Europe
5
Expansion
3
Expected
4
Fda
18
Fda acceptance
4
Genetown
3
Global
46
Growing
6
Growth
65
Health
4
Infection
3
Libtayo
8
Liver
4
Market
125
N/a
193
Ntla-2001
5
Ongoing
5
Order
5
Pharm-country
4
Phase 1
7
Phase 3
15
Positive
10
Reach
4
Report
43
Research
17
Results
13
Review
8
Sanofi
6
Set
6
Study
4
System
5
Teva
8
Therapeutics
26
Therapy
7
Treatment
26
Trial
8
Urticaria
5
Entities
3m company
9
Abbott laboratories
43
Abbvie inc.
130
Acadia pharmaceuticals inc.
3
Adc therapeutics sa
3
Albemarle corporation
8
Alcon inc.
4
Alkermes plc
5
Alnylam pharmaceuticals, inc.
4
Alvotech lux holdings s.a.s.
83
Amgen inc.
83
Antares pharma, inc.
4
Aptargroup, inc.
5
Astellas pharma inc
27
Astrazeneca plc
85
Avadel pharmaceuticals plc
4
Bausch health companies inc.
33
Baxter international inc.
25
Becton, dickinson and company
4
Biogen inc.
28
Bristol-myers squibb company
37
Checkmate pharmaceuticals, inc.
4
Csl ltd
6
Cti biopharma corp.
4
Denali therapeutics inc.
5
Eli lilly and company
61
Endo international plc
28
Galapagos nv
3
Gilead sciences, inc.
10
Glaxosmithkline plc
148
Grifols sa
4
Icon plc
3
Intellia therapeutics, inc.
6
Ionis pharmaceuticals, inc.
4
Jazz pharmaceuticals plc
8
Johnson & johnson
80
Kamada ltd.
85
Koninklijke philips n.v.
12
Mallinckrodt plc
15
Medtronic plc
9
Morgan stanley
5
Neurocrine biosciences, inc.
3
Novartis ag
206
Novo nordisk a/s
15
Obseva sa
3
Orange
6
Perrigo company
6
Pfizer, inc.
29
Prestige consumer healthcare inc.
4
Puma biotechnology inc
4
Reckitt benckiser group plc
11
Regeneron pharmaceuticals, inc.
72
Sanofi
224
Takeda pharmaceutical company limited
20
Taro pharmaceutical industries ltd.
5
Teva pharmaceutical industries limited
64
Teva pharmaceutical industries ltd
632
Thermo fisher scientific inc
8
Ucb s.a.
7
Viatris inc.
103
Symbols
ABBV
211
ABT
253
ALNY
78
ALPMF
70
ALPMY
70
AMGN
170
AMRN
34
AZN
214
AZNCF
174
BAX
45
BDX
34
BHC
30
BIIB
53
BMRN
29
BMY
119
BNTX
167
BSX
25
BY
26
CMXHF
22
FNCTF
49
GILD
64
GLAXF
271
GLPG
39
GLPGF
39
GOOG
35
GOOGL
35
GSK
335
IGMS
37
INCY
121
IPHA
109
IPHYF
81
JNJ
576
KPTI
25
KYMR
29
LLY
335
MDT
45
MOBV
65
MOR
39
MPSYF
36
MRNA
34
NKTR
46
NVO
139
NVS
330
NVSEF
285
OCX
35
PFE
153
PRGO
112
PRVB
283
PTCT
35
RCFA
83
REGN
255
RLYB
34
SNY
4551
SNYNF
3609
TAK
60
TEVJF
224
TMO
43
TXMD
34
VTRS
87
VXRT
36
Exchanges
Nasdaq
224
Nyse
143
Crawled Date
2024 - 03 - 11
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 01 - 30
2
2023 - 10 - 04
3
2023 - 08 - 30
2
2023 - 07 - 21
2
2023 - 07 - 10
2
2023 - 04 - 13
3
2023 - 01 - 25
2
2022 - 11 - 29
2
2022 - 11 - 21
2
2022 - 09 - 30
2
2022 - 09 - 28
2
2022 - 09 - 27
2
2022 - 09 - 26
2
2022 - 09 - 15
3
2022 - 09 - 12
3
2022 - 09 - 08
3
2022 - 09 - 05
3
2022 - 08 - 03
3
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 24
3
2022 - 06 - 07
2
2022 - 05 - 31
3
2022 - 05 - 20
2
2022 - 04 - 07
2
2022 - 04 - 04
2
2022 - 03 - 26
2
2022 - 02 - 28
2
2022 - 02 - 26
2
2022 - 02 - 18
2
2022 - 02 - 11
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 02 - 04
1
2022 - 01 - 31
1
2022 - 01 - 28
1
2022 - 01 - 19
2
2022 - 01 - 11
1
2022 - 01 - 07
1
2021 - 12 - 13
1
2021 - 12 - 11
1
2021 - 12 - 08
1
2021 - 11 - 12
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 10 - 25
1
2021 - 10 - 22
1
2021 - 10 - 20
1
2021 - 10 - 14
1
2021 - 10 - 08
2
2021 - 10 - 07
1
2021 - 10 - 05
1
2021 - 10 - 04
1
2021 - 09 - 30
1
2021 - 09 - 29
1
2021 - 09 - 28
1
Crawled Time
00:00
16
00:20
3
01:00
5
02:00
8
03:00
5
04:00
5
05:00
9
06:00
12
07:00
9
08:00
8
08:20
1
09:00
12
10:00
1
11:00
7
12:00
16
12:15
1
12:20
4
12:30
1
13:00
8
13:20
3
14:00
2
14:30
1
15:00
7
15:30
5
16:00
5
16:20
2
17:00
6
18:00
9
19:00
6
20:00
4
20:20
3
21:00
8
22:00
15
23:00
17
Source
ir.vtvtherapeutics.com
1
www.biospace.com
31
www.globenewswire.com
15
www.prnewswire.com
177
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Sanofi
symbols :
TEVJF
save search
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-9.51%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-0.62%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-8.98%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-4.01%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-6.93%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-0.94%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
|
-5.88%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
4.14%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-4.66%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-1.06%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.25%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
-18.83%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-0.02%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.39%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.97%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-4.25%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
2.99%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-0.6%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-1.16%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-5.58%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-7.72%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.91%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.46%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.93%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
2.74%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-5.03%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
4.01%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.58%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-5.43%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.41%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.5%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.26%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.64%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023
Published:
2024-03-11
(Crawled : 17:00)
- prnewswire.com
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-11.36%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.71%
|
O:
0.57%
H:
0.0%
C:
0.0%
report
global
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-4.98%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.27%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-5.01%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.01%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-4.65%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-5.41%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
9.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-6.69%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
27.56%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-14.3%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-9.36%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.6%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-3.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.95%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-3.48%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.79%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.81%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
7.74%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-4.07%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published:
2024-02-20
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.38%
|
O:
2.72%
H:
0.0%
C:
-0.8%
TEVA
|
$13.01
1.01%
0.0%
8.9M
|
Health Technology
|
-1.08%
|
O:
1.31%
H:
0.67%
C:
-0.91%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.1%
|
O:
2.53%
H:
0.0%
C:
0.0%
antibody
meeting
teva
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.488
-17.59%
1.7K
|
Health Technology
|
-55.26%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-4.41%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.94
0.79%
52K
|
Manufacturing
|
-54.46%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-4.88%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.57%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.93%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.51%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$541.144
-19.1%
24
|
Health Technology
|
8.23%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.69
0.02%
29K
|
Professional, Scientific, and T...
|
12.17%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
1.82%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.83%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.44%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
1.97%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.77%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.89%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-25.58%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-4.44%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-1.11%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
14.97%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.73%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.17%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.8%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.13
0.93%
0.93%
470K
|
Health Technology
|
-17.68%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-5.01%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.2%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-20.69%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.2%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.13
1.73%
1.7%
340K
|
Health Technology
|
-6.1%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-7.65%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.2%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.19%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.35%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.06%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.61%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.7%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
12.64%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.6%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published:
2024-02-08
(Crawled : 05:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
471.43%
|
O:
-14.29%
H:
16.67%
C:
0.0%
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-2.54%
|
O:
0.82%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.05%
|
O:
-1.64%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-4.17%
|
O:
-0.34%
H:
0.0%
C:
-1.2%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.4%
|
O:
-1.57%
H:
0.26%
C:
-0.47%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-3.4%
|
O:
-0.48%
H:
0.16%
C:
0.0%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
2.59%
|
O:
-0.96%
H:
5.91%
C:
3.74%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-6.47%
|
O:
-1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.86%
|
O:
-2.25%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-8.1%
|
O:
0.38%
H:
0.34%
C:
-0.72%
america
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-12.32%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
3.65%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.55%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
38.86%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-12.49%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-5.65%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.65%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.25%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
3.73%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-0.24%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-1.83%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-4.46%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.55%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
|
-12.73%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.61%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-13.97%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published:
2024-01-30
(Crawled : 23:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-15.58%
|
O:
4.34%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
5.21%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
5.7%
|
O:
3.41%
H:
0.0%
C:
-2.45%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-17.63%
|
O:
0.0%
H:
1.38%
C:
0.26%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-4.74%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-12.05%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
3.84%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
1.8%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.95%
|
O:
1.75%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.36%
|
O:
0.82%
H:
0.12%
C:
-1.64%
market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
5.21%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
5.7%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-4.74%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-12.05%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
3.84%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
1.8%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.95%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.12
-0.97%
-0.98%
290K
|
Health Technology
|
8.5%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.36%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-13.58%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published:
2024-01-23
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
1.0%
|
O:
-2.34%
H:
0.43%
C:
0.43%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
1.8%
|
O:
-2.16%
H:
1.17%
C:
1.17%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-12.34%
|
O:
0.46%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-3.35%
|
O:
0.17%
H:
1.33%
C:
0.94%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-12.63%
|
O:
-0.96%
H:
0.3%
C:
0.28%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
2.68%
|
O:
-0.76%
H:
0.38%
C:
0.13%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
2.28%
|
O:
0.37%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-6.84%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-9.5%
|
O:
-2.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
4.45%
|
O:
-1.27%
H:
0.8%
C:
0.69%
drug
hospital
infection
therapeutics
growth
market
Paracetamol Market to grow by USD 791.9 million from 2022 to 2027, North America accounts for 37% of market growth- Technavio
Published:
2024-01-17
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
3.62%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
1.78%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
million
market
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.